POWERFUL YET CAREFUL WITHOUT RELEASING ACTIVE AGENTS INTO THE WOUND SUPPORTS ANTIMICROBIAL STEWARDSHIP Sorbact® is a registered trademark of ABIGO Medical AB EFFECTIVE AGAINST THE TOP FIVE WHO PATHOGENS CLINICALLY PROVEN IN MORE THAN 40 STUDIES INCLUDING MORE THAN 7,000 PATIENTS WINNING ON ALL FRONTS SORBACT® – PROVEN TO PREVENT AND TREAT WOUND INFECTION Based on natural processes and physical interactions, Sorbact® removes bacteria, irreversibly binding them to its surface to reduce bioburden and support wound healing. By this mode of action, Sorbact® dressings may lower the use of antibiotics and provide a contribution in the management and prevention of wound infection. 1 Resistance is not likely to occur from binding of microorganisms. 1. Chadwick P. and Ousey K. 2019. Bacterial-binding dressings in the management of wound healing and infection prevention: a narrative review . J Wound Care. 28(6):370-382 For more information visit sorbact.com Follow us on LinkedIn In some regions, Sorbact® is available as Cutimed® Sorbact®, Leukomed® Sorbact®, Cutimed® Sorbion® Sorbact®, Cutimed® Siltec® Sorbact®. ABIGO Medical AB Ekonomivägen 5 · SE-436 33 Askim · Sweden · Phone: +46 31 748 49 50 2021-12 3
Share
Download PDF file
Build your own flipbook